Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kirtika H. Asrani"'
Publikováno v:
Journal of Nucleic Acids, Vol 2018 (2018)
Alpha-1-antitrypsin (AAT) deficiency is a genetic disorder that produces inactive/defective AAT due to mutations in the SERPINA1 gene encoding AAT. This disease is associated with decreased activity of AAT in the lungs and deposition of excessive def
Externí odkaz:
https://doaj.org/article/e2a344f5f9dc486393462777e4964734
Autor:
Kirtika H. Asrani, Aatman S. Doshi
Publikováno v:
Cancer Immunology and Immunotherapy ISBN: 9780128233979
Tumor heterogeneity can be attributed to the varying growth rate, ability to metastasize, drug resistance, and failure in therapy among the many characteristics of them being of an aggressive phenotype. Yet for cancer to propagate further with its he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0941030d0bd76bdf0e8aff11838e2533
https://doi.org/10.1016/b978-0-12-823397-9.00025-9
https://doi.org/10.1016/b978-0-12-823397-9.00025-9
Autor:
Gulzar Ahmad, Nadia Tasnim Ahmed, Amedeo Amedei, Mansoor M. Amiji, Kirtika H. Asrani, Federico Boem, Kevin A. Cassady, Yu Chen, Patty A. Culp, Jeremiah D. Degenhardt, Danielle E. Dettling, Mustafa B.A. Djamgoz, Aatman S. Doshi, Eyad Elkord, Laetitia Firmenich, Lauren M. Gauthier, Hazem E. Ghoneim, Taichiro Goto, Ilse Hernandez-Aguirre, Hae Lin Jang, Yongsheng Li, Xiang Liu, Gerardo G. Mackenzie, Chad May, Lara Scheherazade Milane, Edda Russo, Abbey A. Saadey, Reem Saleh, Varun Sasidharan Nair, Shiladitya Sengupta, Ting Su, Salman M. Toor, Amir Yousif, Shurong Zhou, Guizhi Zhu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a61abb19f336a0ec05483d3a462bf4f
https://doi.org/10.1016/b978-0-12-823397-9.09989-0
https://doi.org/10.1016/b978-0-12-823397-9.09989-0
Autor:
Romesh R. Subramanian, Jeffrey M Brown, Rebecca L Miller, Jeremiah D. Farelli, Kirtika H. Asrani, Mary R Stahley, Christopher J. Cheng
Publikováno v:
RNA Biology. :1-7
mRNA based therapies hold great promise for the treatment of genetic diseases. However, this therapeutic approach suffers from multiple challenges including the short half-life of exogenously administered mRNA and subsequent protein production. Modul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c95d75bc58c0e4526c554d18dc558f67
https://doi.org/10.1080/15476286.2018.1450054
https://doi.org/10.1080/15476286.2018.1450054
Publikováno v:
RNA biology. 15(7)
Arginase I (ARG1) deficiency is an autosomal recessive urea cycle disorder, caused by deficiency of the enzyme Arginase I, resulting in accumulation of arginine in blood. Current Standard of Care (SOC) for ARG1 deficiency in patients or those having
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142a0433a5dbd653086b7da389bffd8e
https://pubmed.ncbi.nlm.nih.gov/29923457
https://pubmed.ncbi.nlm.nih.gov/29923457
Autor:
Kirtika H. Asrani, Cleo Isaacs, Tayeba Khan, Lucy S. Jun, Romesh R. Subramanian, Jeremiah D. Farelli, Daniel S. Roseman, Fabienne Rajas
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2018, 26 (3), pp.814-821. ⟨10.1016/j.ymthe.2018.01.006⟩
Molecular Therapy, Cell Press, 2018, 26 (3), pp.814-821. ⟨10.1016/j.ymthe.2018.01.006⟩
Glycogen storage disease type Ia (GSD1a) is an inherited metabolic disorder caused by the deficiency of glucose-6-phosphatase (G6Pase). GSD1a is associated with life-threatening hypoglycemia and long-term liver and renal complications. We examined th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f0933a87b2cba1fcb035e6b7f207bb
https://www.hal.inserm.fr/inserm-02379178/document
https://www.hal.inserm.fr/inserm-02379178/document
Autor:
Kirtika H. Asrani, Joanna S deBear, Melissa A. Lasaro, Romesh R. Subramanian, Anumeha Shah, Jeremiah D. Farelli, Cleo Isaacs, Christopher J. Cheng, Mary R Stahley
Publikováno v:
Nucleic acid therapeutics. 28(2)
Messenger RNA (mRNA) is a promising new class of therapeutics that has potential for treatment of diseases in fields such as immunology, oncology, vaccines, and inborn errors of metabolism. mRNA therapy has several advantages over DNA-based gene ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44fe68fd83b1d5913b3d65fade6a4be7
https://pubmed.ncbi.nlm.nih.gov/29437538
https://pubmed.ncbi.nlm.nih.gov/29437538
Autor:
Bernhard Uehleke, Kirtika H. Asrani, Hardik D. Ashar, Jean-Michel Jeannin, Andreas Wirz-Ridolfi, Hans P. Ogal, Robert Jütte, Reimar Banis, Mona Semalty, Marc Schlaeppi, Ajay Semalty, Vandana S. Panda
Publikováno v:
Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine. 24:183-185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f14980581fbb3f7a1c0b6199002f10b5
https://doi.org/10.1159/000178605
https://doi.org/10.1159/000178605
Autor:
Ajay Semalty, Hans P. Ogal, Vandana S. Panda, Kirtika H. Asrani, Mona Semalty, Reimar Banis, Andreas Wirz-Ridolfi, Bernhard Uehleke, Hardik D. Ashar, Jean-Michel Jeannin, Robert Jütte, Marc Schlaeppi
Publikováno v:
Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine. 24:186-187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e571d74abb63270bf1982de4ce64307f
https://doi.org/10.1159/000178494
https://doi.org/10.1159/000178494
Autor:
Kirtika H. Asrani, Mona Semalty, Vandana S. Panda, Bernhard Uehleke, Robert Jütte, Hardik D. Ashar, Ajay Semalty, Marc Schlaeppi, Jean-Michel Jeannin, Reimar Banis, Andreas Wirz-Ridolfi, Hans P. Ogal
Publikováno v:
Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine. 24:130-131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d873f133101d9d65fcffbea5bc930527
https://doi.org/10.1159/000178580
https://doi.org/10.1159/000178580